http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104829696-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2015-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104829696-B |
titleOfInvention | Open loop Rubiaceae type cyclic peptide, the pharmaceutical composition using it as active component, its preparation method and application |
abstract | The present invention provides open loop Rubiaceae type cyclic peptide, pharmaceutical composition using it as active component, it is used as the inhibitor of NF κ B signal paths, its preparation method and its application in the related inflammation disease and the medicine of cancer for treating and preventing NF κ B signal path abnormal activations.The open loop Rubiaceae type cyclic peptide of the present invention, the cyclic compound formed is condensed through peptide bond by 1 D α alanine, 2 L α alanine, the N methyl L α tyrosine of 3 substitutions to be a kind of.Preferred structure formula is the open loop Rubiaceae type cyclic peptide of (1 3), is the inhibitor of NF κ B signal paths. |
priorityDate | 2015-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.